TrialFuture oncology (London, England)2025

Adverse events self-reported by patients with extensive-stage small-cell lung cancer in the phase III CASPIAN study.

Mustafa Özgüroğlu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.